In a crowding market, seek differentiation
Health Canada stokes already heated competition. Recent results suggest that many LPs have struggled to ramp production and have therefore missed consensus expectations for sales volumes. While such growing pains are to be expected, on the positive side, quarterly earnings also suggest that cannabis prices have climbed higher due to supply constraints. Read more from Canaccord Genuity on how Maricann is positioned to be a meaningful low-cost producer in Canada.